|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Investments, at fair value | |||||||||||||||||
| Non-controlled non-affiliated | |||||||||||||||||
| Non-controlled affiliated | |||||||||||||||||
| Controlled | |||||||||||||||||
| Total investments, at fair value | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Restricted cash and cash equivalents | |||||||||||||||||
| Interest and dividend receivable | |||||||||||||||||
| Receivable from unsettled transactions | |||||||||||||||||
| Unrealized appreciation on foreign currency forward contracts | |||||||||||||||||
| Deferred tax assets | |||||||||||||||||
| Other assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities | |||||||||||||||||
| Debt (net of deferred financing costs of $8,809 and $5,841, respectively) | |||||||||||||||||
| Distributions payable | |||||||||||||||||
| Interest and other debt financing costs payable | |||||||||||||||||
| Management fees payable | |||||||||||||||||
| Incentive fees payable | |||||||||||||||||
| Deferred tax liabilities | |||||||||||||||||
| Unrealized depreciation on foreign currency forward contracts | |||||||||||||||||
| Unrealized depreciation on interest rate swaps | |||||||||||||||||
| Accrued expenses and other liabilities | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Net assets | |||||||||||||||||
| Common stock, par value $0.001 per share (200,000,000 shares authorized, 36,845,952 and 36,969,285 shares issued and outstanding, respectively) | |||||||||||||||||
| Paid-in capital in excess of par value | |||||||||||||||||
| Accumulated earnings (loss) | |||||||||||||||||
| Total net assets | |||||||||||||||||
| Total liabilities and net assets | |||||||||||||||||
| Net asset value per share | |||||||||||||||||
Loading...